CN107693524A - A kind of preparation method containing aspirin and clopidogrel - Google Patents
A kind of preparation method containing aspirin and clopidogrel Download PDFInfo
- Publication number
- CN107693524A CN107693524A CN201710995638.7A CN201710995638A CN107693524A CN 107693524 A CN107693524 A CN 107693524A CN 201710995638 A CN201710995638 A CN 201710995638A CN 107693524 A CN107693524 A CN 107693524A
- Authority
- CN
- China
- Prior art keywords
- clopidogrel
- aspirin
- preparation
- layer
- stomach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a kind of preparation method containing aspirin and clopidogrel, a kind of preparation method containing aspirin and clopidogrel, comprises the following steps:S1 prepares aspirin layer inner core;S2 is coated to aspirin layer inner core, and then obtains enteric layer;S3 is coated to enteric layer, and then obtains clopidogrel or its medicinal salt deposit;S4 is coated to clopidogrel or its medicinal salt deposit, and then obtains layer soluble in the stomach, and is pressed into the tablet containing aspirin and clopidogrel;Beneficial effect:Beneficial effect:Tablet prepared by a kind of preparation method of the tablet containing aspirin and clopidogrel of the present invention can effectively treat pathological condition, angiocarpy and the cerebrovascular system disease induced by platelet aggregation, and to coat of the stomach not damaged, be advantageous to the clothes for patients use to aspirin intolerance.
Description
Technical field
The present invention relates to pharmaceutical arts, more particularly to a kind of preparation side of the tablet containing aspirin and clopidogrel
Method.
Background technology
The current medicament comprising aspirin and clopidogrel is generally the shape of tablet, gel capsule or single dose bag
Formula, then Aspirin tablet may cause coat of the stomach to damage in the form of the above, prepare a kind of new above-mentioned tablet and overcome
The defects of causing coat of the stomach to damage is actually necessary.
The content of the invention
It is an object of the invention to provide a kind of preparation method of the tablet containing aspirin and clopidogrel, to solve
The shortcomings that easily causing coat of the stomach to damage in the prior art.
Technical scheme:
A kind of preparation method containing aspirin and clopidogrel, comprises the following steps:
S1. aspirin layer inner core is prepared;
S2. aspirin layer inner core is coated, and then obtains enteric layer;
S3. enteric layer is coated, and then obtains clopidogrel or its medicinal salt deposit;
S4. clopidogrel or its medicinal salt deposit are coated, and then obtain layer soluble in the stomach, and be pressed into containing aspirin and chlorine pyrrole
The tablet of Gray.
The aspirin layer inner core includes acetylsalicylic acid or its pharmaceutical salts.
The layer soluble in the stomach includes at least one stomach tolerance polymer and the weight at least 15% of polymer is resistant to relative to stomach
Sodium bicarbonate.
The enteric layer includes hydroxypropyl ethyl cellulose and POLYPROPYLENE GLYCOL.
Beneficial effect:Tablet prepared by a kind of preparation method of the tablet containing aspirin and clopidogrel of the present invention can have
Pathological condition, angiocarpy and the cerebrovascular system disease that the treatment of effect is induced by platelet aggregation, and to coat of the stomach not damaged, favorably
In the clothes for patients use to aspirin intolerance.
Embodiment
Herein below is to combine specific preferred embodiment further description made for the present invention, it is impossible to is assert
The specific implementation of the present invention is confined to these explanations.
A kind of preparation method containing aspirin and clopidogrel, comprises the following steps:
S1. aspirin layer inner core is prepared;
S2. aspirin layer inner core is coated, and then obtains enteric layer;
S3. enteric layer is coated, and then obtains clopidogrel or its medicinal salt deposit;
S4. clopidogrel or its medicinal salt deposit are coated, and then obtain layer soluble in the stomach, and be pressed into containing aspirin and chlorine pyrrole
The tablet of Gray.
The aspirin layer inner core includes acetylsalicylic acid or its pharmaceutical salts.
The layer soluble in the stomach includes at least one stomach tolerance polymer and the weight at least 15% of polymer is resistant to relative to stomach
Sodium bicarbonate.
The enteric layer includes hydroxypropyl ethyl cellulose and POLYPROPYLENE GLYCOL.
For general technical staff of the technical field of the invention, without departing from the inventive concept of the premise,
Some simple deduction or replace can also be made, should all be considered as belonging to protection scope of the present invention.
Claims (4)
1. a kind of preparation method containing aspirin and clopidogrel, it is characterised in that comprise the following steps:
S1. aspirin layer inner core is prepared;
S2. aspirin layer inner core is coated, and then obtains enteric layer;
S3. enteric layer is coated, and then obtains clopidogrel or its medicinal salt deposit;
S4. clopidogrel or its medicinal salt deposit are coated, and then obtain layer soluble in the stomach, and be pressed into containing aspirin and chlorine pyrrole
The tablet of Gray.
A kind of 2. preparation method containing aspirin and clopidogrel according to claim 1, it is characterised in that the Ah Si
Woods layer inner core includes acetylsalicylic acid or its pharmaceutical salts.
3. a kind of preparation method containing aspirin and clopidogrel according to claim 1, it is characterised in that described soluble in the stomach
Layer includes at least one stomach tolerance polymer and the sodium bicarbonate of the weight at least 15% of polymer is resistant to relative to stomach.
A kind of 4. preparation method containing aspirin and clopidogrel according to claim 1, it is characterised in that the enteric
Layer includes hydroxypropyl ethyl cellulose and POLYPROPYLENE GLYCOL.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710995638.7A CN107693524A (en) | 2017-10-23 | 2017-10-23 | A kind of preparation method containing aspirin and clopidogrel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710995638.7A CN107693524A (en) | 2017-10-23 | 2017-10-23 | A kind of preparation method containing aspirin and clopidogrel |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107693524A true CN107693524A (en) | 2018-02-16 |
Family
ID=61181469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710995638.7A Withdrawn CN107693524A (en) | 2017-10-23 | 2017-10-23 | A kind of preparation method containing aspirin and clopidogrel |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107693524A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109288805A (en) * | 2018-11-21 | 2019-02-01 | 北京汇诚瑞祥医药技术有限公司 | A kind of compound aspirin bisulfate clopidogrel clad sheet and preparation method |
CN115212180A (en) * | 2022-09-03 | 2022-10-21 | 深圳市信宜特科技有限公司 | Compound preparation of aspirin and clopidogrel hydrogen sulfate and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1993112A (en) * | 2004-07-29 | 2007-07-04 | 赛诺菲-安万特 | Pharmaceutical multilayer tablet for controlled release of active ingredients with highly pH-dependent solubility |
CN103906506A (en) * | 2011-09-14 | 2014-07-02 | 波曾公司 | Controlled dosing of clopidogrel with gastric acid inhibition therapies |
CN103957895A (en) * | 2011-11-02 | 2014-07-30 | 韩国联合制药株式会社 | Complex agent containing clopidogrel and aspirin |
CN105407877A (en) * | 2013-08-02 | 2016-03-16 | 赛诺菲 | Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel |
WO2017037741A1 (en) * | 2015-09-02 | 2017-03-09 | Sun Pharmaceutical Industries Ltd | Compact solid dosage form of aspirin and clopidogrel |
WO2017160101A1 (en) * | 2016-03-16 | 2017-09-21 | 한국유나이티드제약 주식회사 | Composite preparation containing clopidogrel and aspirin |
-
2017
- 2017-10-23 CN CN201710995638.7A patent/CN107693524A/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1993112A (en) * | 2004-07-29 | 2007-07-04 | 赛诺菲-安万特 | Pharmaceutical multilayer tablet for controlled release of active ingredients with highly pH-dependent solubility |
CN103906506A (en) * | 2011-09-14 | 2014-07-02 | 波曾公司 | Controlled dosing of clopidogrel with gastric acid inhibition therapies |
CN103957895A (en) * | 2011-11-02 | 2014-07-30 | 韩国联合制药株式会社 | Complex agent containing clopidogrel and aspirin |
CN105407877A (en) * | 2013-08-02 | 2016-03-16 | 赛诺菲 | Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel |
WO2017037741A1 (en) * | 2015-09-02 | 2017-03-09 | Sun Pharmaceutical Industries Ltd | Compact solid dosage form of aspirin and clopidogrel |
WO2017160101A1 (en) * | 2016-03-16 | 2017-09-21 | 한국유나이티드제약 주식회사 | Composite preparation containing clopidogrel and aspirin |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109288805A (en) * | 2018-11-21 | 2019-02-01 | 北京汇诚瑞祥医药技术有限公司 | A kind of compound aspirin bisulfate clopidogrel clad sheet and preparation method |
CN109288805B (en) * | 2018-11-21 | 2019-05-31 | 北京汇诚瑞祥医药技术有限公司 | A kind of compound aspirin bisulfate clopidogrel clad sheet and preparation method |
CN115212180A (en) * | 2022-09-03 | 2022-10-21 | 深圳市信宜特科技有限公司 | Compound preparation of aspirin and clopidogrel hydrogen sulfate and preparation method thereof |
CN115212180B (en) * | 2022-09-03 | 2024-05-10 | 深圳市信宜特科技有限公司 | Compound preparation of aspirin and clopidogrel bisulfate and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3094322B1 (en) | Administration of tasimelteon under fasted conditions | |
MX2015011896A (en) | Mosapride sustained-release preparation for providing pharmacological clinical effects with once-a-day administration. | |
MX354328B (en) | Composite formulation comprising multi-unit spheroidal tablet (must) encapsulated in hard capsule and method for preparing same. | |
CN101972236A (en) | Sustained release preparation containing pirfenidone | |
CN104013592A (en) | Memantine hydrochloride slow-release pill and preparation method thereof | |
CN107693524A (en) | A kind of preparation method containing aspirin and clopidogrel | |
JP2018039810A5 (en) | ||
CN104107174A (en) | Health hollow capsule | |
RU2015143475A (en) | PRODUCT AND METHOD FOR TREATING DIARRHEA | |
JP2016512493A5 (en) | ||
JP2017061488A5 (en) | ||
CN107669690A (en) | A kind of tablet containing aspirin and clopidogrel | |
JP2019529572A5 (en) | ||
CN103301087A (en) | Production process of enteric gelatin hollow capsules | |
WO2011108882A3 (en) | Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient | |
CA3156182A1 (en) | Methods of treating conditions related to the s1p1 receptor | |
WO2016086776A1 (en) | Antifungal compound formulation containing chlorogenic acid and application thereof | |
CN105434400B (en) | A kind of preparation method of the minimum enteric-coated micro-pill of proton pump inhibitor | |
CN104147197A (en) | Medicine for treating tinea pedis and preparation method thereof | |
CN106924737A (en) | Glycine betaine and proton pump inhibitor compound preparation of a kind of stabilization and preparation method thereof | |
CN108992394A (en) | A kind of preparation method of pseudoephedrine hydrochloride slow release preparation | |
WO2011100668A4 (en) | Methods and compositions of civamide to treat diseases of the intestines | |
CN105362271A (en) | Pharmaceutical composition containing moxifloxacin for resisting pulmonary fibrosis | |
CN106619562A (en) | Enteric soluble capsule material | |
CN104586826B (en) | Levocarnitine and its derivative are preparing the application in treating or preventing idiopathic pulmonary fibrosis drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180216 |
|
WW01 | Invention patent application withdrawn after publication |